Search Results - "Béresniak, Ariel"

A Markov-model simulation of IVF programs for PCOS patients indicates that coupling myo-Inositol with rFSH is cost-effective for the Italian Health System by Beresniak, Ariel, Russo, Michele, Forte, Gianpiero, Laganà, Antonio Simone, Oliva, Mario Montanino, Aragona, Cesare, Chiantera, Vito, Unfer, Vittorio

“…Accumulating evidence suggests that oral supplementation with myo-Inositol (myo-Ins) is able to reduce the amount of gonadotropins and days of controlled…”
Get full text

Preventive screening of open‐angle glaucoma: an innovative machine learning risk assessment tool based on health insurance claims data by Bremond‐Gignac, Dominique, Dairazalia, Sanchez‐Cortes, Jihyun, Lee‐Engler, Maxime, Coriou, Duru, Gerard, Nicolas, Loeillot, Ariel, Beresniak

“…Purpose Despite progress in management of open‐angle glaucoma, early diagnosis remains difficult due to delayed ophthalmologist consultation. Early glaucoma…”
Get full text

The FLURESP European commission project: cost-effectiveness assessment of ten public health measures against influenza in Italy: is there an interest in COVID-19 pandemic? by Beresniak, Ariel, Napoli, Christian, Oxford, John, Daruich, Alejandra, Niddam, Laurent, Duru, Gérard, Tozzi, Alberto E, Atti, Marta Ciofi Degli, Dupont, Danielle, Rizzo, Caterina, Bremond-Gignac, Dominique

“…The FLURESP project is a public health research funded by the European Commission, with the objective to design a methodological framework to assess the…”
Get full text

Limitations of the methods used for calculating quality-adjusted life-year values by Duru, Gérard, Auray, Jean Paul, Béresniak, Ariel, Lamure, Michel, Paine, Abby, Nicoloyannis, Nicolas

“…To test the validity of the techniques used to calculate quality-adjusted life-year (QALY) values based on utility functions, using a real population dataset…”
Get full text

Cost-effectiveness modelling of use of urea breath test for the management of Helicobacter pylori-related dyspepsia and peptic ulcer in the UK by Pritchard, D. Mark, Bornschein, Jan, Beales, Ian, Beresniak, Ariel, Salhi, Hocine, Malfertheiner, Peter

“…ObjectiveClinical data comparing diagnostic strategies in the management of Helicobacter pylori-associated diseases are limited. Invasive and noninvasive…”
Get full text

Cost-Effectiveness of Mitral Valve Repair Versus Replacement by Biologic or Mechanical Prosthesis by Beresniak, Ariel, MD, PhD, Sabatier, Brigitte, PharmD, Achouh, Paul, MD, PhD, Menasché, Philippe, MD, PhD, Fabiani, Jean-Noel, MD, PhD

“…Background Surgical treatment strategies for mitral valve disease have progressively shifted toward repair given the better survival outcomes with this type of…”
Get full text

Direct Cost-Modeling of Rheumatoid Arthritis According to Disease Activity Categories in France by BERESNIAK, Ariel, GOSSEC, Laure, GOUPILLE, Philippe, SARAUX, Alain, BAMBERGER, Marion, BREGMAN, Bruno, DUPONT, Danielle

“…The objective of this cost-of-illness study was to assess the use of direct medical resources, excluding drug costs, by patients with rheumatoid arthritis (RA)…”
Get full text

Relationships between black tea consumption and key health indicators in the world: an ecological study by Beresniak, Ariel, Duru, Gerard, Berger, Genevieve, Bremond-Gignac, Dominique

“…Objectives The aim of this study was to investigate potential statistical relationships between black tea consumption and key health indicators in the world…”
Get full text

Responsible Research and Innovation Associated With Risk Communication and Public Engagement on Health Emergency Preparedness at the Local Level by Possenti, Valentina, De Mei, Barbara, Kurchatova, Anna, Green, Manfred, Drager, Kåre Harald, Villa, Roberta, d'Onofrio, Alberto, Saadatian-Elahi, Mitra, Moore, Vanessa, Brattekas, Kjersti, Karnaki, Pania, Beresniak, Ariel, Popa, Mircea I., Greco, Donato

“…Responsible Research and Innovation (RRI) associated with public health emergency preparedness (PHEP) and response pose major challenges to the scientific…”
Get full text

Advantages and limitations of utility assessment methods in rheumatoid arthritis by BERESNIAK, Ariel, RUSSELL, Anthony S, HARAOUI, Boulos, BESSETTE, Louis, BOMBARDIER, Claire, DURU, Gerard

“…Utility assessment and cost-utility analyses such as costs/quality-adjusted life-years (QALY) are frequently presented to demonstrate the value of new…”
Get full text

Cost-effectiveness modelling of percutaneous coronary interventions in stable coronary artery disease by Beresniak, Ariel

“…The objective of this study is to develop a cost-effectiveness model comparing drug eluting stents(DES) vs bare metal stent(BMS) in patients suffering of…”
Get full text

Assessment of yellow fever epidemic risk: an original multi-criteria modeling approach by Briand, Sylvie, Beresniak, Ariel, Nguyen, Tim, Yonli, Tajoua, Duru, Gerard, Kambire, Chantal, Perea, William

“…Yellow fever (YF) virtually disappeared in francophone West African countries as a result of YF mass vaccination campaigns carried out between 1940 and 1953…”
Get full text

Modelling Cost-Effectiveness of Biologic Treatments Based on Disease Activity Scores for the Management of Rheumatoid Arthritis in Spain by Beresniak, Ariel, Ariza-Ariza, Rafael, Garcia-Llorente, Jose Francisco, Ramirez-Arellano, Antonio, Dupont, Danielle

“…Background. The objective of this simulation model was to assess the cost-effectiveness of different biological treatment strategies based on levels of disease…”
Get full text

Is there an alternative to quality-adjusted life years for supporting healthcare decision making? by Beresniak, Ariel, Dupont, Danielle

“…Over the years, a number of criticisms have been raised about the robustness of the Quality-Adjusted Life Years (QALY) indicator and its use in cost-utility…”
Get more information

Helicobacter pylori “Test‐and‐Treat” strategy with urea breath test: A cost‐effective strategy for the management of dyspepsia and the prevention of ulcer and gastric cancer in Spain—Results of the Hp‐Breath initiative by Beresniak, Ariel, Malfertheiner, Peter, Franceschi, Francesco, Liebaert, Francois, Salhi, Hocine, Gisbert, Javier P.

“…Background Data from clinical trials comparing Helicobacter pylori (H. pylori) management strategies in patients with dyspepsia are limited. Cost‐effectiveness…”
Get full text

Reevaluating health metrics: Unraveling the limitations of disability-adjusted life years as an indicator in disease burden assessment by Beresniak, Ariel, Bremond-Gignac, Dominique, Dupont, Danielle, Duru, Gerard

“…In 1993, the World Bank released a global report on the efficacy of health promotion, introducing the disability-adjusted life years (DALY) as a novel…”
Get full text

Early detection of accelerated aging and cellular decline (AACD): A consensus statement by Cesari, Matteo, Cherubini, Antonio, Guralnik, Jack M., Beresniak, Ariel, Rodriguez-Mañas, Leocadio, Inzitari, Marco, Walston, Jeremy

“…The cellular hallmarks of accelerated aging and their clinical expression may be grouped using the terms ‘accelerated aging and cellular decline’ (AACD) and/or…”
Get full text

Validation of the Underlying Assumptions of the Quality-Adjusted Life-Years Outcome: Results from the ECHOUTCOME European Project by Beresniak, Ariel, Medina-Lara, Antonieta, Auray, Jean Paul, De Wever, Alain, Praet, Jean-Claude, Tarricone, Rosanna, Torbica, Aleksandra, Dupont, Danielle, Lamure, Michel, Duru, Gerard

“…Background Quality-adjusted life-years (QALYs) have been used since the 1980s as a standard health outcome measure for conducting cost-utility analyses, which…”
Get full text

Optimizing Diabetes Management Using a Low-Calorie Diet in Saudi Arabia: A Cost-Benefit Analysis by Al Sifri, Saud, Aldahash, Raed, de Luis Roman, Daniel-Antonio, Amin, Ahmed, Camprubi-Robles, María, Kerr, Kirk W., Juusti-Hawkes, Alina, Beresniak, Ariel

“…Background Low-calorie diets, high in protein and low in carbohydrates, are commonly recommended for patients with pre-diabetes and type 2 diabetes. The…”
Get full text

Business analysis for a sustainable, multi-stakeholder ecosystem for leveraging the Electronic Health Records for Clinical Research (EHR4CR) platform in Europe by Dupont, Danielle, Beresniak, Ariel, Sundgren, Mats, Schmidt, Andreas, Ainsworth, John, Coorevits, Pascal, Kalra, Dipak, Dewispelaere, Marc, Moor, Georges De

“…Highlights • The EHR4CR technological platform can enhance and speed up clinical research. • A business model is needed for reusing electronic health records…”
Get full text